In Reversal, FDA Calls for Limits on Who Takes Alzheimer’s Drugs

Under fire for approving a questionable drug for all Alzheimer’s‘s patients, the Food and Drug Administration on Thursday largely narrowed down the previous recommendation and now recommends that only those with mild memory or thinking problems should take it. This turnaround, quite unusual for a drug that has only been on the market for a …